MSD has announced the approval from the FDA of its combination therapy Recarbrio (imipenem, cilastatin and relebactam) in the treatment of adult patients with complicated urinary tract infections (cUTI) and complicated...
Latest articles
Make Your Content Marketing Strategy Useful – Do It in Visuals
Do execs’ eyes gloss over when you present the brand’s content marketing strategy? Is the text-based document collecting dust on your team’s desks? Ensure that your content marketing strategy is understood – and used –...
Recursion raises $121m for AI-led drug discovery
Funds will fuel in house pipeline and tech
RNAi Therapy Gets Breakthrough Status for Primary Hyperoxaluria Type 1
The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to DCR-PHXC (Dicerna Pharmaceuticals) for the treatment of patients with primary hyperoxaluria type 1 (caused by a mutation in the AGXT...
Crizanlizumab Granted Priority Review for Sickle Cell Pain Crises Prevention
The Food and Drug Administration (FDA) has accepted for Priority Review the Biologics License Application (BLA) for crizanlizumab (SEG101; Novartis) for the prevention of vaso-occlusive crises in patients with sickle...
Goede content heeft een originele invalshoek
Content die weinig traffic genereert hoeft niet meteen te worden afgeschreven. Met een aantal aanpassingen kun je content die weinig aandacht oplevert nieuw leven in blazen.
